References
- Vasconcelos T, Sarmento B, Costa P. (2007). Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today, 12:1068–1075.
- Yoshioka M, Hancock BC, Zografi G. (1995). Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitate. J Pharm Sci, 84:983–986.
- Matsumoto T, Zografi G. (1999). Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res, 16:1722–1728.
- Berggren J, Alderborn G. (2004). Long-term stabilization potential of poly(vinylpyrrolidone) for amorphous lactose in spray-dried composites. Eur J Pharm Sci, 21:209–215.
- Tobyn M, Brown J, Dennis AB, Fakes M, Gao Q, Gamble J, Khimyak YZ, McGeorge G, Patel C, Sinclair W, Timmins P, Yin S. (2009). Amorphous drug–PVP dispersions: Application of theoretical, thermal and spectroscopic analytical techniques to the study of a molecule with intermolecular bonds in both the crystalline and pure amorphous state. J Pharm Sci, 98:3456–3468.
- Serajuddin AT. (1999). Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci, 88:1058–1066.
- Food and Drug Administration. FDA Guidance for Industry: Dissolution testing of immediate release solid oral dosage forms. August 1997, http://www.fda.gov/cder/Guidance/1713bp1.pdf.
- International conference on harmonization of technical requirements for registration of pharmaceuticals for human use (August 2009). Pharmaceutical Development–Q8 (R2). http://www.ich.org/cache/compo/363-272-1.html.
- Yu LX. (2008). Pharmaceutical quality by design product and process development, understanding, and control. Pharm Res, 25:781–791.
- Gregory FC. (1992). A Bayesian method for the induction of probabilistic networks from data. Mach Learn 9:309–347.
- Jansen R, Yu H, Greenbaum D, Kluger Y, Krogan NJ, Chung S et al. (2003). A Bayesian networks approach for predicting protein-protein interactions from genomic data. Science, 302:449–453.
- Xue Y, Chen H, Jin C, Sun Z, Yao X. (2006). NBA-Palm: Prediction of palmitoylation site implemented in Naïve Bayes algorithm. BMC Bioinformatics, 7:458.
- Wilson WI, Peng Y, Augsburger LL. (2005). Comparison of statistical analysis and Bayesian networks in the evaluation of dissolution performance of BCS Class II model drugs. J Pharm Sci, 94:2764–2776.
- Kikuchi S, Onuki Y, Yasuda A, Hayashi Y, Takayam K, (2011). Latent structure analysis in pharmaceutical formulation using Kohonen’s self-organizing map and a Bayesian network. J Pharm Sci, 100:964–975.
- Moore JW, Flanner HH. (1996). Mathematical comparison of curves with an emphasis on in-vitro dissolution profiles. Pharm Technol, 20:64–74.
- Watanabe Y, Koizumi K, Zama Y, Kiriyama M, Matsumoto Y, Matsumoto M. (1995). New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Biol Pharm Bull, 18:1308–1310.
- Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K. (1996). Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull, 44:2121–2127.
- Motomura Y. (2009). Predictive modeling of everyday behavior from large-scale data. Synthesiology, 2:1–12.
- Ulrich B, Stewart EM, Gavin NC, Kenny MG, Stefan S. (2002). Bayesian probabilistic network modeling of remifentanil and propofol interaction on wakeup time after closed-loop controlled anesthesia. J Clin Monit Comput, 17:31–36.